Pancreatic cancer is the 7th highest cause of cancer-related death worldwide. By the time of diagnosis, pancreatic cancer is frequently at an advanced stage and is associated with short survival times (<5 months) and a significant reduction in patient health-related quality of life.Treatment for pancreatic cancer includes surgery, radiation, and/or chemotherapy. Targeted and immunotherapies are being developed and explored in ongoing clinical trials. The objectives of this study were to:
1. Identify the symptoms and the impact of the disease and its treatment on patients in order to develop a conceptual model of pancreatic cancer to guide patientcentered outcomes measurement in clinical trials.
2. Assess the suitability of selected PRO instruments in this population.
Authors: Degboe A, Kitchen H, Aldhouse N, Trigg A, Herman JM., Narang A, Hodgin M, Johnson C, Halling K